Behavioural despair in rats: A new model sensitive to antidepressant treatments

European Journal of Pharmacology

Volumn 47, Issue 4, 1978, Pages 379-391

  Porsolt, Roger D ^a   Anton, Guy ^a   Blavet, Nadine ^a   Jalfre, Maurice ^a  

^a Centre de Recherche Delalande   (France)

Author keywords

Depression; ECS Behavioural model; MAOI; Mianserin; Tricyclic antidepressants

Indexed keywords

ANTIDEPRESSANT AGENT; IMIPRAMINE;

ANIMAL; ARTICLE; DEPRESSION; DISEASE MODEL; DRUG EFFECT; ELECTRIC SHOCK; HUMAN; MALE; MOTOR ACTIVITY; PHYSIOLOGY; RAT; REM SLEEP; SLEEP DEPRIVATION; TIME;

ANIMAL; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; ELECTROSHOCK; HUMAN; IMIPRAMINE; MALE; MOTOR ACTIVITY; RATS; SLEEP DEPRIVATION; SLEEP, REM; TIME FACTORS;

EID: 0018268297     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(78)90118-8     Document Type: Article

References (63)

1. A double blind comparative trial of nomifensin and desimipramine in depression
2. Ergebnisse eines offenen und eines Doppelblindversuches von Nomifensin im Vergleich zu Imipramin
3. Clinical evaluation of a new tricyclic antidepressant iprindole
4. The forgotten treatment modality in bipolar illness: psychotherapy
5. The making and breaking of affectional bonds. I. Aetiology and psychopathology in the light of attachment theory
6. Clinical and pharmacological effects of treatment with a new antidepressant
7. Etude neuroélectrophysiologique chez le chat d'un nouveau psychotrope: latoloxatone
8. Severe depressive mood changes following slow-release intramuscular fluphenazine injection
9. Effect of iprindole on amine uptake in man
10. Doppelblind-studie mit dem neuen Antidepressivum Viloxazin im Vergleich zu Imipramin bei 50 stationären Patientinnen
11. The pharmacology of iprindole, a new antidepressant
12. Intéraction de divers psychotropes avec cinq effects de la réserpine chez la souris et le chat: ptose palpébrale, hypothermie, hypomotilité, catalepsie et pointes pontogéniculo-occipitales: intérêt des tests en psychopharmacologie
13. Activité de la toloxatone, d'antidépresseurs et de divers autres antagonistes de la réserpine sur trois épreuves de comportement chez la souris traitée par la nialamide
14. Profil psychopharmacologique d'un antidépresseur potential appartenant à la série de l'hydroxymethyl-5-oxazolidinone-2
15. Animal pharmacology of viloxazine (Vivalan)
16. Induced depression in monkeys
17. Depressive Syndrome im Verlauf neuroleptischer Therapie
18. Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum
19. 8-Amino-4-methyl-1-4-phenyl-1,2,3,4-tetrahydroisoquinoline, a new antidepressant
20. Convulsive therapy and other biological treatments
21. Clinical and EEG effects of GB 94, a ‘tetracyclic’ antidepressant (EEG model: discovery of a new psychotropic drug)
22. Effects of some centrally acting agents in rats after intraventricular injections of 6-hydroxydopamine
23. Methods for assessing the interaction of agents with 5-hydroxytryptamine neurons and receptors in the brain
24. Three double blind comparative trials of mianserine (ORG GB 94) and amitryptyline in the treatment of depressive illness
25. The effect of a new tetracyclic antidepressant compound, ORG GB 94, on the turnover of dopamine, noradrenaline and serotonin in the rat brain
26. Study of a new oxazolidinone with original MAO inhibiting properties
27. Molecular geometry of inhibitors of the uptake of catecholamines amd serotonin in synaptosomal preparations of rat brain
28. Pharmacology and biochemistry of fenfluramine
29. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities
30. Kombinierte Schlafentzugs/Chlorimipramine Behandlung endogener Depressionen
31. Central effects of mianserin and danitracen—new antidepressant drugs of unknown mechanism of action
32. Central action of nomifensine
33. 2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine hydrochloride, a potential psychotropic agent
34. Un nouvel antidepresseur, le 69276: essai thérapeutique, originalité du produit
35. Depression and learned helplessness in man
36. Controlled trial of nomifensin (HOE 984) and viloxazine in the treatment of depression in the elderly
37. Paradoxical sleep rebound in the rat. Effects of physical procedures involved in intracisternal injection
38. The serotoninergic neurotransmitter system in the affective disorders — and evaluation of the antidepressant and antimanic effects of fenfluramine
39. A comparative clinical trial of ORG GB 94 and imipramine in the treatment of depression in general practice
40. Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity
41. Depression: a new animal model sensitive to antidepressant treatments
42. Effects of sleep deprivation on mood and central amine metabolism in depressed patients
43. Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes
44. Iprindole and Imipramine in Non-Psychotic Depressed Out-Patients
45. A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices
46. Antidepressive Behandlung mittels Schlafentzug
47. The effect of nomifensine on the depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats
48. Neuropharmacology of the Affective Disorders
49. Totaler und partieller Schlafentzug in der Behandlung von Depressionen
50. Separation in infant dogs: emotional response and motivational consequences
51. Failure to escape traumatic shock
52. Open-field chez le rat: interrelations entre locomotion exploration et émotivité
53. The Use of the Cavity-Rim Cervical Cap in a Family Physician's Office.
54. Etude clinique d'un nouvel antidépresseur: le 69276
55. Nomifensine and its derivatives as possible tools for studying amine
56. Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine
57. Different central effects of 5-HT antagonists mianserin and cyproheptadine
58. Vivalan Symposium
59. A. Review of REM sleep deprivation: REM sleep reduction effects on depression syndromes
60. Mianserin versus amitriptyline. A double blind trial evaluated by the AMP System
61. Controlled clinical trial of a new antidepressant (ORG GB 94) of novel chemical formulation
62. 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis